Statements (65)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:employs |
Over 1000 people
|
| gptkbp:focusesOn |
Biosimilars
Branded Drugs Generic_Drugs |
| gptkbp:hasPart |
Clinical Trials
Compliance Customer Service Diversity and Inclusion Finance Financial Planning Human Resources Manufacturing Market Research Public Relations Risk Management Strategic Planning Succession Planning Talent Acquisition Training and Development Workforce Planning Business Development Employee Engagement Product Development Quality Assurance Supply Chain Optimization Market Access Regulatory Affairs Legal Affairs Product Management Corporate Communications Market Expansion Sales Operations Sales Strategy Investor Relations Business Continuity Planning Product Launches Sales and Marketing Partnerships and Alliances Internal Audit Pharmacovigilance Merger and Acquisition Strategy Business_Intelligence Corporate_Social_Responsibility Customer_Relationship_Management Data_Management Digital_Transformation IT_Services Performance_Management Project_Management Research_and_Development Supply_Chain_Management Environmental_Health_and_Safety |
| gptkbp:hasProductLine |
Diabetes
Cardiovascular CNS Anti-infectives |
| gptkbp:headquarteredIn |
gptkb:United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupin Europe
|
| gptkbp:isKnownFor |
Innovative drug development
Affordable medications High-quality generics |
| gptkbp:operatesIn |
Pharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Lupin_Limited
|
| gptkbp:wasFoundedIn |
2003
|